Christie Canaria, Ph.D., is an Interagency Policy Specialist in the Technology Partnerships Office (TPO) at the National Institute of Standards and Technology (NIST). She provides executive support for federal, cross-agency initiatives to advance technology translation in the Lab-to-Market arena.
Dr. Canaria oversees various projects and workstreams as Program Manager for NIST’s Research and Development initiative under the Creating Helpful Incentives to Produce Semiconductors for America (CHIPS) Act. She also supports the Federal Laboratory Consortium for Technology Transfer (FLC), its committees, and its working groups. Christie serves the White House Office of Science and Technology Policy National Science & Technology Council’s Lab to Market Subcommittee, its working groups, and its strategy team.
Dr. Canaria’s career experience confirms her belief that “The fun stuff in science happens at the interfaces of different fields.”
Before joining TPO, Christie provided programmatic oversight to the I-Corps™ at the National Institute of Health (NIH). That program’s goal was to support training to help project teams at NIH-funded small businesses overcome critical obstacles to innovation and commercialization. She was also a Program Director at the National Cancer Institute’s Small Business Innovation Research Development Center, which supported a portfolio of technologies, including biological imaging, biosensors, and nanotechnology.
Before her federal service, Dr. Canaria managed an optical microscopy facility at the Department of Energy’s Lawrence Berkeley National Laboratory and worked as an imaging expert at the Caltech Biological Imaging Center. There she developed multi-dimensional and time-lapse confocal imaging techniques. Dr. Canaria has also worked for a small biotech business as it transitioned from a start-up into an IPO.
Christie holds a Ph.D. in chemistry from the California Institute of Technology and a B.S. from the University of California - San Diego. She was awarded the AAAS Science & Technology Policy Fellowship and began science policy work in Washington, D.C., in 2013.